Sponsored: Bayer
Bayer makes safety studies public
Bayer launched a special website which provides access to safety studies of plant protection products. With this initiative, Bayer aims to further increase transparency about their resources.
The website contains summaries of studies into human and environmental effects of approximately 20 substances. In addition to the summaries, a number of complete studies are already available for 1 substance, imidacloprid. In 2018 and beyond, summaries and studies will also be made available for other substances. Only persons or parties without commercial interests are allowed access to the studies.
Complex matter
Bayer realizes that drug authorization and the science behind it are complex. In addition to the studies, the website also offers videos, infographics and other information material to explain this.
By making the safety studies public and explaining them, Bayer wants to contribute to an open dialogue about the safety of our products. For more information visit the transparency website or read the two pager'Demystifying Science: Enabling access to safety studiesabout this initiative.
